From October 1, 2023 to November 17, 2023, the company has repurchased 6,106,800 shares, representing 0.54% for CNY 100.02 million. With this, the company has completed the repurchase of 9,015,780 shares, representing 0.8% for CNY 150 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 CNY | +0.47% | +0.47% | -0.53% |
29/04 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.53% | 247.86Cr | |
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.